HORSHAM, Pennsylvanie, 3 mai 2024 /PRNewswire/ — Myonex a finalisé l’acquisition préalablement annoncée des services pharmaceutiques de CREAPHARM. Cette transaction permet de combiner capacités et flexibilité au service des entreprises pharmaceutiques et biotechnologiques aux stades…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.